Relation: approved_to_treat
holds between a therapeutic procedure or chemical substance and a disease or phenotypic feature for which it is approved for treatment to some level of clinical trial. Note that in terms of REPODB narrow mappings, terms containing ‘suspended’, ‘terminated’ or ‘withdrawn’ should be mapped onto associations using this term for which ‘negated: true’ is asserted.
URI: biolink:approved_to_treat
Domain and Range
Treatment -> 0..* DiseaseOrPhenotypicFeature
Parents
- is_a: treats
Children
Used by
Other properties
| Exact Mappings: | NCIT:C172573 | |
| Narrow Mappings: | NCIT:R172 | |
| NCIT:regimen_has_accepted_use_for_disease | ||
| REPODB:clinically_tested_approved_unknown_phase | ||
| REPODB:clinically_tested_suspended_phase_0 | ||
| REPODB:clinically_tested_suspended_phase_1 | ||
| REPODB:clinically_tested_suspended_phase_1_or_phase_2 | ||
| REPODB:clinically_tested_suspended_phase_2 | ||
| REPODB:clinically_tested_suspended_phase_2_or_phase_3 | ||
| REPODB:clinically_tested_suspended_phase_3 | ||
| REPODB:clinically_tested_terminated_phase_0 | ||
| REPODB:clinically_tested_terminated_phase_1 | ||
| REPODB:clinically_tested_terminated_phase_1_or_phase_2 | ||
| REPODB:clinically_tested_terminated_phase_2 | ||
| REPODB:clinically_tested_terminated_phase_2_or_phase_3 | ||
| REPODB:clinically_tested_terminated_phase_3 | ||
| REPODB:clinically_tested_withdrawn_phase_0 | ||
| REPODB:clinically_tested_withdrawn_phase_1 | ||
| REPODB:clinically_tested_withdrawn_phase_1_or_phase_2 | ||
| REPODB:clinically_tested_withdrawn_phase_2 | ||
| REPODB:clinically_tested_withdrawn_phase_2_or_phase_3 | ||
| REPODB:clinically_tested_withdrawn_phase_3 |